Nanotechnology toward advancing personalized medicine

Jason H. Sakamoto, Biana Godin, Ye Hu, Elvin Blanco, Anne L. van de Ven, Adaikkalam Vellaichamy, Matthew B. Murphy, Saverio La Francesca, Terry Schuenemeyer, Bruce Given, Anne Meyn, Mauro Ferrari

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationHandbook of Clinical Nanomedicine
Subtitle of host publicationLaw, Business, Regulation, Safety, and Risk
PublisherPan Stanford Publishing Pte. Ltd.
Pages1347-1411
Number of pages65
Volume2
ISBN (Electronic)9789814669238
ISBN (Print)9789814669221
DOIs
StatePublished - May 2 2016
Externally publishedYes

Fingerprint

Nanofluidics
Medical nanotechnology
Plasma diagnostics
Biomarkers
Nanotechnology
Drug products
Medicine
Nanoparticles
Regenerative Medicine

Keywords

  • Biobarriers
  • Biomarkers
  • Chemotherapeutics
  • Clinical translation
  • Clinical translation
  • Controlled drug release
  • Diagnostics
  • Drug development
  • Nanofluidics
  • Nanomedicine
  • Nanoparticle
  • Nanotechnology
  • Nanovectors
  • Patient advocate
  • Personalized medicine
  • Precision medicine
  • Regenerative medicine
  • Regulatory challenges

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Engineering(all)
  • Materials Science(all)

Cite this

Sakamoto, J. H., Godin, B., Hu, Y., Blanco, E., van de Ven, A. L., Vellaichamy, A., ... Ferrari, M. (2016). Nanotechnology toward advancing personalized medicine. In Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk (Vol. 2, pp. 1347-1411). Pan Stanford Publishing Pte. Ltd.. https://doi.org/10.4032/9789814669238

Nanotechnology toward advancing personalized medicine. / Sakamoto, Jason H.; Godin, Biana; Hu, Ye; Blanco, Elvin; van de Ven, Anne L.; Vellaichamy, Adaikkalam; Murphy, Matthew B.; La Francesca, Saverio; Schuenemeyer, Terry; Given, Bruce; Meyn, Anne; Ferrari, Mauro.

Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk. Vol. 2 Pan Stanford Publishing Pte. Ltd., 2016. p. 1347-1411.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sakamoto, JH, Godin, B, Hu, Y, Blanco, E, van de Ven, AL, Vellaichamy, A, Murphy, MB, La Francesca, S, Schuenemeyer, T, Given, B, Meyn, A & Ferrari, M 2016, Nanotechnology toward advancing personalized medicine. in Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk. vol. 2, Pan Stanford Publishing Pte. Ltd., pp. 1347-1411. https://doi.org/10.4032/9789814669238
Sakamoto JH, Godin B, Hu Y, Blanco E, van de Ven AL, Vellaichamy A et al. Nanotechnology toward advancing personalized medicine. In Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk. Vol. 2. Pan Stanford Publishing Pte. Ltd. 2016. p. 1347-1411 https://doi.org/10.4032/9789814669238
Sakamoto, Jason H. ; Godin, Biana ; Hu, Ye ; Blanco, Elvin ; van de Ven, Anne L. ; Vellaichamy, Adaikkalam ; Murphy, Matthew B. ; La Francesca, Saverio ; Schuenemeyer, Terry ; Given, Bruce ; Meyn, Anne ; Ferrari, Mauro. / Nanotechnology toward advancing personalized medicine. Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk. Vol. 2 Pan Stanford Publishing Pte. Ltd., 2016. pp. 1347-1411
@inbook{babeb2dfb9244f3a990ec260e57d4902,
title = "Nanotechnology toward advancing personalized medicine",
keywords = "Biobarriers, Biomarkers, Chemotherapeutics, Clinical translation, Clinical translation, Controlled drug release, Diagnostics, Drug development, Nanofluidics, Nanomedicine, Nanoparticle, Nanotechnology, Nanovectors, Patient advocate, Personalized medicine, Precision medicine, Regenerative medicine, Regulatory challenges",
author = "Sakamoto, {Jason H.} and Biana Godin and Ye Hu and Elvin Blanco and {van de Ven}, {Anne L.} and Adaikkalam Vellaichamy and Murphy, {Matthew B.} and {La Francesca}, Saverio and Terry Schuenemeyer and Bruce Given and Anne Meyn and Mauro Ferrari",
year = "2016",
month = "5",
day = "2",
doi = "10.4032/9789814669238",
language = "English (US)",
isbn = "9789814669221",
volume = "2",
pages = "1347--1411",
booktitle = "Handbook of Clinical Nanomedicine",
publisher = "Pan Stanford Publishing Pte. Ltd.",

}

TY - CHAP

T1 - Nanotechnology toward advancing personalized medicine

AU - Sakamoto, Jason H.

AU - Godin, Biana

AU - Hu, Ye

AU - Blanco, Elvin

AU - van de Ven, Anne L.

AU - Vellaichamy, Adaikkalam

AU - Murphy, Matthew B.

AU - La Francesca, Saverio

AU - Schuenemeyer, Terry

AU - Given, Bruce

AU - Meyn, Anne

AU - Ferrari, Mauro

PY - 2016/5/2

Y1 - 2016/5/2

KW - Biobarriers

KW - Biomarkers

KW - Chemotherapeutics

KW - Clinical translation

KW - Clinical translation

KW - Controlled drug release

KW - Diagnostics

KW - Drug development

KW - Nanofluidics

KW - Nanomedicine

KW - Nanoparticle

KW - Nanotechnology

KW - Nanovectors

KW - Patient advocate

KW - Personalized medicine

KW - Precision medicine

KW - Regenerative medicine

KW - Regulatory challenges

UR - http://www.scopus.com/inward/record.url?scp=85015857298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015857298&partnerID=8YFLogxK

U2 - 10.4032/9789814669238

DO - 10.4032/9789814669238

M3 - Chapter

SN - 9789814669221

VL - 2

SP - 1347

EP - 1411

BT - Handbook of Clinical Nanomedicine

PB - Pan Stanford Publishing Pte. Ltd.

ER -